76 related articles for article (PubMed ID: 20004941)
21. The Roles of Insulin-Like Growth Factor 2 mRNA-Binding Protein 2 in Cancer and Cancer Stem Cells.
Cao J; Mu Q; Huang H
Stem Cells Int; 2018; 2018():4217259. PubMed ID: 29736175
[TBL] [Abstract][Full Text] [Related]
22. Different levels of let-7d expression modulate response of FaDu cells to irradiation and chemotherapeutics.
Lamperska KM; Kolenda T; Teresiak A; Kowalik A; Kruszyna-Mochalska M; Jackowiak W; Bliźniak R; Przybyła W; Kapałczyńska M; Kozlowski P
PLoS One; 2017; 12(6):e0180265. PubMed ID: 28665983
[TBL] [Abstract][Full Text] [Related]
23. High expression of HMGA2 predicts poor survival in patients with clear cell renal cell carcinoma.
Na N; Si T; Huang Z; Miao B; Hong L; Li H; Qiu J; Qiu J
Onco Targets Ther; 2016; 9():7199-7205. PubMed ID: 27932890
[TBL] [Abstract][Full Text] [Related]
24. Epigenetic regulation of human retinoblastoma.
Singh U; Malik MA; Goswami S; Shukla S; Kaur J
Tumour Biol; 2016 Nov; 37(11):14427-14441. PubMed ID: 27639385
[TBL] [Abstract][Full Text] [Related]
25. Orchestrating epigenetic roles targeting ocular tumors.
Wen X; Lu L; He Z; Fan X
Onco Targets Ther; 2016; 9():1001-9. PubMed ID: 27013893
[TBL] [Abstract][Full Text] [Related]
26. Raf kinase inhibitor protein (RKIP) inhibits the cell migration and invasion in human glioma cell lines in vitro.
Lei X; Chang L; Ye W; Jiang C; Zhang Z
Int J Clin Exp Pathol; 2015; 8(11):14214-20. PubMed ID: 26823735
[TBL] [Abstract][Full Text] [Related]
27. High-mobility group A2 overexpression is an unfavorable prognostic biomarker for nasopharyngeal carcinoma patients.
Liu Z; Wu K; Yang Z; Wu A
Mol Cell Biochem; 2015 Nov; 409(1-2):155-62. PubMed ID: 26183485
[TBL] [Abstract][Full Text] [Related]
28. Correlation of High Mobility Group Box-1 Protein (HMGB1) with Clinicopathological Parameters in Primary Retinoblastoma.
Singh MK; Singh L; Pushker N; Sen S; Sharma A; Chauhan FA; Kashyap S
Pathol Oncol Res; 2015 Sep; 21(4):1237-42. PubMed ID: 26118980
[TBL] [Abstract][Full Text] [Related]
29. Let-7a inhibits migration, invasion and epithelial-mesenchymal transition by targeting HMGA2 in nasopharyngeal carcinoma.
Wu A; Wu K; Li J; Mo Y; Lin Y; Wang Y; Shen X; Li S; Li L; Yang Z
J Transl Med; 2015 Mar; 13():105. PubMed ID: 25884389
[TBL] [Abstract][Full Text] [Related]
30. High mobility group a proteins as tumor markers.
Pallante P; Sepe R; Puca F; Fusco A
Front Med (Lausanne); 2015; 2():15. PubMed ID: 25859543
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-21 Down-regulates Rb1 Expression by Targeting PDCD4 in Retinoblastoma.
Shen F; Mo MH; Chen L; An S; Tan X; Fu Y; Rezaei K; Wang Z; Zhang L; Fu SW
J Cancer; 2014; 5(9):804-12. PubMed ID: 25520758
[TBL] [Abstract][Full Text] [Related]
32. EpCAM knockdown alters microRNA expression in retinoblastoma--functional implication of EpCAM regulated miRNA in tumor progression.
Beta M; Khetan V; Chatterjee N; Suganeswari G; Rishi P; Biswas J; Krishnakumar S
PLoS One; 2014; 9(12):e114800. PubMed ID: 25502397
[TBL] [Abstract][Full Text] [Related]
33. Role of miRNA let-7 and its major targets in prostate cancer.
Wagner S; Ngezahayo A; Murua Escobar H; Nolte I
Biomed Res Int; 2014; 2014():376326. PubMed ID: 25276782
[TBL] [Abstract][Full Text] [Related]
34. HMGA1 and HMGA2 expression and comparative analyses of HMGA2, Lin28 and let-7 miRNAs in oral squamous cell carcinoma.
Sterenczak KA; Eckardt A; Kampmann A; Willenbrock S; Eberle N; Länger F; Kleinschmidt S; Hewicker-Trautwein M; Kreipe H; Nolte I; Murua Escobar H; Gellrich NC
BMC Cancer; 2014 Sep; 14():694. PubMed ID: 25245141
[TBL] [Abstract][Full Text] [Related]
35. Ficus carica latex prevents invasion through induction of let-7d expression in GBM cell lines.
Tezcan G; Tunca B; Bekar A; Yalcin M; Sahin S; Budak F; Cecener G; Egeli U; Demir C; Guvenc G; Yilmaz G; Erkan LG; Malyer H; Taskapilioglu MO; Evrensel T; Bilir A
Cell Mol Neurobiol; 2015 Mar; 35(2):175-87. PubMed ID: 25212824
[TBL] [Abstract][Full Text] [Related]
36. Profiles of extracellular miRNAs in the aqueous humor of glaucoma patients assessed with a microarray system.
Tanaka Y; Tsuda S; Kunikata H; Sato J; Kokubun T; Yasuda M; Nishiguchi KM; Inada T; Nakazawa T
Sci Rep; 2014 May; 4():5089. PubMed ID: 24867291
[TBL] [Abstract][Full Text] [Related]
37. Plasma microRNA-320, microRNA-let-7e and microRNA-21 as novel potential biomarkers for the detection of retinoblastoma.
Liu SS; Wang YS; Sun YF; Miao LX; Wang J; Li YS; Liu HY; Liu QL
Biomed Rep; 2014 May; 2(3):424-428. PubMed ID: 24748987
[TBL] [Abstract][Full Text] [Related]
38. MicroRNAs in the Neural Retina.
Andreeva K; Cooper NG
Int J Genomics; 2014; 2014():165897. PubMed ID: 24745005
[TBL] [Abstract][Full Text] [Related]
39. The genomic landscape of retinoblastoma: a review.
Thériault BL; Dimaras H; Gallie BL; Corson TW
Clin Exp Ophthalmol; 2014; 42(1):33-52. PubMed ID: 24433356
[TBL] [Abstract][Full Text] [Related]
40. Targeted expression of suicide gene by tissue-specific promoter and microRNA regulation for cancer gene therapy.
Danda R; Krishnan G; Ganapathy K; Krishnan UM; Vikas K; Elchuri S; Chatterjee N; Krishnakumar S
PLoS One; 2013; 8(12):e83398. PubMed ID: 24391761
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
